- · Swiss SME valuations vary by as much as 2–3x depending on sector, with SaaS and healthcare commanding 7.5–12.5x EBITDA while manufacturing and hospitality trade at 3–6x.
- · The Swiss M&A market recorded 502 transactions and USD 166.8bn in total value in 2025, yet deal concentration is narrowing around fewer, larger transformative transactions.
- · Most SME owners below the CHF 5–10M EBITDA threshold remain outside the reach of structured advisory, exposing them to significant information asymmetry.
- · Sector-aware buyer matching is increasingly material to realising full enterprise value in the current market.
When two companies post identical EBITDA figures, the intuitive assumption is that they should attract broadly comparable valuations. In Switzerland's current M&A environment, that assumption is incorrect by a factor of two to three. The sector in which a business operates has become one of the most consequential determinants of transaction value, and the distance between the highest and lowest multiples in the market has rarely been wider.
Data from Val Index's February 2026 sector reports puts the range in sharp relief. SaaS and B2B software businesses across the approximately 4,200 firms tracked in Switzerland are transacting at deal multiples of 7.5–12.5x EBITDA. Healthcare clinic groups, across roughly 55 consolidating platforms, are clearing 7.5–11.5x. At the other end of the spectrum, general Swiss SMEs average 4.0–7.0x according to Berney Associés' 2026 market overview, while manufacturing businesses typically trade between 3.0–6.0x and hospitality assets between 3.0–7.0x, carrying a sector risk premium of 8–12%.
That is not a rounding difference. For an owner running CHF 2M of EBITDA, the sector premium alone is worth between CHF 3M and CHF 10M in headline proceeds. The multiple is the message.
The divergence is not arbitrary. It reflects a set of structural forces that have been building for several years and are now expressing themselves clearly in transaction data.
The SNB's policy rate, cut to the 0% range by early 2026, has lowered the cost of capital available to financial and strategic buyers, supporting valuation recovery across the market. That is a broadly constructive development. The issue is that lower cost of capital does not benefit all sellers equally. Buyers with access to cheap financing deploy it selectively, and their preferences are concentrated in assets that offer recurring revenue, defensible margins, and scalability, characteristics found disproportionately in software and healthcare.
PwC Switzerland's mid-year 2026 M&A outlook describes the market in terms of a K-shaped pattern: deal values trending upward while transaction volumes remain measured, with value concentrating in fewer transformative megadeals led by well-capitalised strategic and financial acquirers. The Swiss market's 2025 figure of 502 transactions totalling USD 166.8bn was the highest volume since 2018, but the distribution of that value is anything but uniform.
The technology sector illustrates the concentration vividly. IFBC's Tech Transactions Monitor for July 2026 recorded 24 software deals and 12 IT services transactions in the four months from January through April 2026 alone, with approximately 50% of buyers being Swiss strategic acquirers. That pace of deal activity reflects organised, well-resourced buyer appetite that is structurally absent in traditional sectors.
Understanding that a sector gap exists is one thing. Accessing the buyers who actually pay sector-premium multiples is another. Here the market has a more persistent structural problem.
Traditional M&A advisory, whether through the Big Four or specialist boutique firms, typically engages only above the CHF 5–10M EBITDA threshold. That is a commercially rational business model for those firms. It is, however, a significant constraint for the median Swiss SME. Over 500,000 SMEs constitute the theoretical transaction universe in Switzerland. More than half of them operate below CHF 1M in EBITDA. For these businesses, buyer access has historically been mediated by local networks, personal referrals, and regional advisors with limited institutional connectivity.
The consequence is informational isolation. A manufacturing business owner in canton Aargau, or a clinic proprietor in canton Vaud, may be entirely unaware that a sector-specialist financial buyer or a strategic acquirer with a roll-up mandate is actively seeking precisely their type of asset. Without structured, sector-aware market exposure, that seller negotiates from a position of incomplete information. The multiple they achieve reflects their network, not their business.
An identically performing industrial company can realise 3–5x fewer multiple points than a comparable business that reaches institutional buyers who recognise and pay for sector premium.
This is not a question of business quality. It is a question of market access.
It is worth being precise about what the current multiple environment is communicating, and what it is not.
High multiples in software and healthcare reflect buyer conviction about the durability and scalability of earnings in those sectors. Capitalisation rates for Swiss SME DCF valuations typically run at 8–12%, adjusted for sector and size. Where buyers have lower perceived risk and higher growth expectations, they compress that discount rate and extend the earnings horizon they are willing to price. The result is a premium multiple. This is not irrational exuberance. It is a coherent expression of risk-adjusted return expectations by sophisticated buyers.
Lower multiples in manufacturing and hospitality reflect the inverse: higher capital intensity, greater revenue cyclicality, limited scalability, and in the case of hospitality, meaningful sector-specific risk premia. A 3–6x manufacturing multiple is not evidence of market dysfunction. It is evidence of a well-functioning market pricing risk accurately.
The observation that matters for SME owners is that this pricing is largely invisible outside structured market venues. Without benchmark data, without sector comparable transactions, and without access to institutional buyers who might pay a strategic premium above the financial buyer floor, most sellers leave value on the table without ever knowing it existed.
The practical implication for owners considering a succession or sale is straightforward, even if implementing it requires deliberate preparation. Sector positioning should inform transaction timing. A healthcare operator with recurring patient revenue and a defensible regional footprint is a different asset to a generalist buyer than to a sector-consolidating private equity platform. Presenting the business in the right context, to the right buyer category, through a channel that reaches institutional participants, changes the reference point from which any negotiation begins.
That framing does not constitute advisory. It is market observation: structured exposure to a broader, sector-literate buyer pool is a material input to transaction outcomes. The Swiss M&A market in 2026 is not one market. It is several markets operating at very different valuations, and the distance between them is measurable, significant, and in large part a function of information asymmetry rather than business fundamentals.
For the 500,000-plus Swiss SMEs that sit below the traditional advisory threshold, understanding which market they are operating in, and finding a venue through which to reach the buyers active in that market, is among the more consequential decisions they will make in preparing for a transaction.
Sources: Val Index SaaS/B2B Software Sector Report (2026-02); Val Index Healthcare Clinics Sector Report (2026-02); Berney Associés, Market Multiples at a Glance (2026); IFBC Tech Transactions Monitor (July 2026); PwC Switzerland, M&A Trends 2026 Mid-Year Outlook; Swiss National Bank; Scalemetrics (2026).